Effect of Papilozumib Oral on Vaginal and Intestinal Microbiota in HPV-Positive Women

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This open-label, single-group study evaluated the effects of a 3-month oral synbiotic dietary supplement on vaginal and intestinal microbiota in women with a positive human papillomavirus (HPV) test. Vaginal and intestinal microbiota were assessed at baseline and after 3 months of supplementation. Secondary assessments included HPV clearance, vaginal health, safety and tolerability, and treatment adherence.
Epistemonikos ID: 134bdc312fc0866905e0ed40fe9a3e6fe5863fd1
First added on: Aug 11, 2026